Details of the Drug

General Information of Drug (ID: DMGICPX)

Drug Name

SF-22

Synonyms

SF-22; MLS000570381; 746609-35-8; SMR000150436; 5-chloro-N-(2-piperidin-1-ylphenyl)thiophene-2-sulfonamide; C15H17ClN2O2S2; AC1M25JT; GTPL6389; SCHEMBL16992615; CHEMBL1377681; cid_2111037; BDBM46888; AOB1317; SYN5052; HMS2341H11; ZINC2647919; MCULE-6902790788; NCGC00356114-04; AS-16418; SR-01000677876-2; Z45692898; 5-chloro-N-(2-piperidinophenyl)thiophene-2-sulfonamide; 5-chloro-N-[2-(piperidin-1-yl)phenyl]thiophene-2-sulfonamide; 5-chloro-N-(2-piperidin-1-ylphenyl)thiophene-2-sulphonamide

Indication

Disease Entry	ICD 11	Status	REF
Autoimmune disease	4A40-4A45	Preclinical	[1]

Drug Type

Small molecular drug

Structure

3D MOL is unavailable

2D MOL

Chemical Identifiers

Formula: C15H17ClN2O2S2
Canonical SMILES: C1CCN(CC1)C2=CC=CC=C2NS(=O)(=O)C3=CC=C(S3)Cl
InChI: InChI=1S/C15H17ClN2O2S2/c16-14-8-9-15(21-14)22(19,20)17-12-6-2-3-7-13(12)18-10-4-1-5-11-18/h2-3,6-9,17H,1,4-5,10-11H2
InChIKey: RXDWTDRPUXJDPY-UHFFFAOYSA-N

Cross-matching ID

PubChem CID: 2111037
ChEBI ID: CHEMBL1377681
TTD ID: D05XIA

Drug-Molecule Activity Atlas (DMA)^NEW

Click to Jump to the Detailed DMA Information of This Drug

Drug ADMET Endpoint Profile (DAE)^NEW

Click to Jump to the Detailed DAE Information of This Drug

References

1	Lysosomes as a therapeutic target. Nat Rev Drug Discov. 2019 Dec;18(12):923-948.